CSIMarket
 


Scpharmaceuticals Inc   (SCPH)
Other Ticker:  
 
 

SCPH's Operating Income Growth by Quarter and Year

Scpharmaceuticals Inc 's Operating Income results by quarter and year




SCPH Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -6.72 -7.17 -10.43
III Quarter September -10.00 -5.91 -8.44 -6.29
II Quarter June -9.42 -6.46 -7.68 -7.34
I Quarter March -7.24 -6.74 -6.65 -8.85
FY   -26.66 -25.83 -29.94 -32.91



SCPH Operating Income third quarter 2022 Y/Y Growth Comment
Scpharmaceuticals Inc in the third quarter 2022 recorded Operating Loss of $ -10.00 millions.

According to the results reported in the third quarter 2022, Scpharmaceuticals Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Scpharmaceuticals Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


SCPH Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Scpharmaceuticals Inc 's third quarter 2022 Operating Income $ -10.00 millions SCPH's Income Statement
Scpharmaceuticals Inc 's third quarter 2021 Operating Income $ -5.91 millions Quarterly SCPH's Income Statement
New: More SCPH's historic Operating Income Growth >>


SCPH Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Scpharmaceuticals Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCPH's III. Quarter Q/Q Operating Income Comment
Current Operating Loss of -10.00 millions by Scpharmaceuticals Inc appear even less good if you take a look at -9.42 millions a quarter before.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc achieved highest sequential Operating Income growth. While Scpharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCPH's III. Quarter Q/Q Operating Income Comment
Recent accomplishment of -10.00 millions by Scpharmaceuticals Inc look even less good if you take a look at -9.42 millions Operating Loss a quarter before.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc achieved highest sequential Operating Income growth. While Scpharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is .


Scpharmaceuticals Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Operating Income 12 Months Ending $ -33.38 $ -29.29 $ -26.32 $ -25.82 $ -26.27
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Scpharmaceuticals Inc ' has realized cumulative trailing twelve months Operating Loss of $ -33 millions in the Sep 30 2022 period.
The results are getting worse as the cumulative Operating Loss is getting bigger from $ -29.29 millions for the period from Jun 30 2022 to Sep 30 2021 and $ -9.42 millions from the TTM period ending Sep 30 2021.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Scpharmaceuticals Inc ' has realized cumulative trailing twelve months Operating Loss of $ -33 millions in the Sep 30 2022 period.
The results are worsening as the cumulative Operating Loss is getting bigger from $ -29.29 millions in the twelve months ending a quarter before and $ -9.42 millions for the twelve months ending in the quarter Sep 30 2021.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
SCPH's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for SCPH's Competitors
Operating Income Growth for Scpharmaceuticals Inc 's Suppliers
Operating Income Growth for SCPH's Customers

You may also want to know
SCPH's Annual Growth Rates SCPH's Profitability Ratios SCPH's Asset Turnover Ratio SCPH's Dividend Growth
SCPH's Roe SCPH's Valuation Ratios SCPH's Financial Strength Ratios SCPH's Dividend Payout Ratio
SCPH's Roa SCPH's Inventory Turnover Ratio SCPH's Growth Rates SCPH's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2022
Universal Security Instruments Inc120.59%$ 120.587 millions
Ethema Health Corporation 114.34%$ 114.335 millions
Carlisle Companies Incorporated109.13%$ 109.129 millions
Catalyst Pharmaceuticals Inc 79.25%$ 79.249 millions
Biogen Inc 65.63%$ 65.630 millions
Viatris Inc 56.63%$ 56.628 millions
Iqvia Holdings Inc 56.29%$ 56.291 millions
Amneal Pharmaceuticals Inc 55.54%$ 55.543 millions
Medpace Holdings Inc 44.89%$ 44.894 millions
Collegium Pharmaceutical inc 44.65%$ 44.653 millions
Stryker Corp40.77%$ 40.767 millions
United Therapeutics Corporation37.43%$ 37.429 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ADMG's Profile

Stock Price

ADMG's Financials

Business Description

Fundamentals

Charts & Quotes

ADMG's News

Suppliers

ADMG's Competitors

Customers & Markets

Economic Indicators

ADMG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071